Episode Details
Back to Episodes
Health Data & Cancer Trials Drive Policy | Ottawa News
Description
Canada’s health advocates are hitting their stride—CMA and Canadian Cancer Society led Ottawa’s lobbying in 2026 with over 200 reports, pushing for seamless health data sharing via Bill S-5. After decades of advocacy, they’re now seeing real wins: patients gaining control of their records, primary care access improved, Indigenous health prioritized, and misinformation tackled. The Cancer Society celebrates the bill as a World Cancer Day milestone, linking it to economic growth by boosting Canada’s weak 4% share of the $82B global clinical trials market. Faster approvals, more jobs, and quicker treatments are on the table—all underpinned by a simple truth: a healthy population drives a healthy economy.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/e08efddce3cb9f80